Walleye Capital LLC Has $1.15 Million Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Walleye Capital LLC raised its holdings in shares of Teladoc Health, Inc. (NYSE:TDOCGet Rating) by 121.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,896 shares of the health services provider’s stock after purchasing an additional 8,731 shares during the quarter. Walleye Capital LLC’s holdings in Teladoc Health were worth $1,147,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. DB Wealth Management Group LLC acquired a new stake in Teladoc Health during the 1st quarter valued at $25,000. McCarthy Asset Management Inc. acquired a new stake in Teladoc Health during the 1st quarter valued at $25,000. City State Bank bought a new position in Teladoc Health during the 4th quarter worth $27,000. GoalVest Advisory LLC bought a new position in Teladoc Health during the 1st quarter worth $31,000. Finally, Standard Family Office LLC bought a new position in Teladoc Health during the 4th quarter worth $41,000. Institutional investors and hedge funds own 92.46% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Guggenheim cut Teladoc Health from a “neutral” rating to a “sell” rating and set a $25.00 price objective on the stock. in a research report on Wednesday, August 17th. Barclays lowered their price objective on Teladoc Health from $45.00 to $42.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 20th. StockNews.com upgraded Teladoc Health to a “sell” rating in a research report on Tuesday, August 9th. The Goldman Sachs Group cut Teladoc Health from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $55.00 to $36.00 in a research report on Thursday, July 28th. Finally, DA Davidson started coverage on Teladoc Health in a research report on Friday, August 12th. They issued a “buy” rating and a $45.00 price target on the stock. Two equities research analysts have rated the stock with a sell rating, twenty-four have given a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $66.88.

Insiders Place Their Bets

In other Teladoc Health news, CFO Mala Murthy sold 4,053 shares of Teladoc Health stock in a transaction that occurred on Monday, June 27th. The stock was sold at an average price of $37.32, for a total value of $151,257.96. Following the completion of the sale, the chief financial officer now directly owns 27,295 shares in the company, valued at $1,018,649.40. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, CFO Mala Murthy sold 4,053 shares of the business’s stock in a transaction that occurred on Monday, June 27th. The stock was sold at an average price of $37.32, for a total transaction of $151,257.96. Following the completion of the sale, the chief financial officer now owns 27,295 shares in the company, valued at $1,018,649.40. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, SVP Daniel Trencher sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 17th. The shares were sold at an average price of $37.50, for a total value of $37,500.00. Following the sale, the senior vice president now owns 26,408 shares of the company’s stock, valued at approximately $990,300. The disclosure for this sale can be found here. Over the last three months, insiders sold 10,151 shares of company stock worth $370,316. 1.55% of the stock is owned by corporate insiders.

Teladoc Health Price Performance

Teladoc Health stock opened at $30.49 on Monday. The stock’s 50 day moving average is $36.06 and its 200 day moving average is $43.49. The company has a debt-to-equity ratio of 0.25, a current ratio of 3.38 and a quick ratio of 3.22. The firm has a market cap of $4.91 billion, a P/E ratio of -0.50 and a beta of 0.86. Teladoc Health, Inc. has a one year low of $27.38 and a one year high of $156.82.

Teladoc Health (NYSE:TDOCGet Rating) last posted its quarterly earnings data on Wednesday, July 27th. The health services provider reported ($0.44) EPS for the quarter, topping analysts’ consensus estimates of ($0.71) by $0.27. The company had revenue of $592.38 million for the quarter, compared to analyst estimates of $586.86 million. Teladoc Health had a negative return on equity of 2.04% and a negative net margin of 441.94%. As a group, research analysts expect that Teladoc Health, Inc. will post -1.54 EPS for the current year.

Teladoc Health Company Profile

(Get Rating)

Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.

Featured Articles

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOCGet Rating).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.